Ozempic Alternatives: Best Options for Weight Loss and Type 2 Diabetes

Ozempic is not the only option, and it is often not even the best one.

Last Updated April 22, 2026

20+ Viable Ozempic alternatives by route

$0-1,200 Monthly cost range across alternatives

24.2% Retatrutide Phase 2 weight loss at 48 weeks

21% Tirzepatide weight loss in SURMOUNT-1 trial

🔑 Key Takeaways

Tirzepatide (Zepbound/Mounjaro) is the strongest FDA-approved alternative to Ozempic, producing more weight loss across head-to-head trials
Wegovy is the same molecule as Ozempic (semaglutide) at a higher dose, FDA-approved for weight management
Retatrutide, a triple agonist in Phase 3, shows the strongest clinical weight-loss data of any GLP-1-class drug ever tested
Compounded semaglutide and tirzepatide are still accessible in 2026 under specific clinical exceptions, but the FDA shortage window closed in 2025 for branded drugs
For people who cannot tolerate GLP-1 GI side effects, AOD-9604, MOTS-c, and CJC-1295 + Ipamorelin offer non-GLP-1 weight-loss support
Over-the-counter options (berberine, psyllium) are real but produce a fraction of the effect of any prescription GLP-1
The right alternative depends on goal: diabetes, weight loss, cost, side-effect tolerance, and whether you want prescription or research-grade material

This guide covers every credible alternative to Ozempic in 2026: FDA-approved GLP-1s, compounded options, emerging research peptides, non-GLP-1 prescription drugs, and over-the-counter options. Each one is rated on efficacy, cost, access, and who it is actually appropriate for.

Why People Look for Ozempic Alternatives

Five main reasons.

Cost. Ozempic retail runs $900-1,200 per month without insurance. Many insurers cover it only for diabetes, not weight loss.
Side effects. Severe nausea, vomiting, constipation, and the newer concerns about gastroparesis and NAION (see our Ozempic side effects guide) push a significant share of users to stop within the first few months.
Plateau or non-response. Roughly 10-15% of users are poor responders who lose little or no weight on semaglutide even at max dose.
Contraindications. Family history of medullary thyroid carcinoma (MTC), severe gastroparesis, or severe pancreatitis history rule out semaglutide entirely.
Shortage history. From 2022-2024 Ozempic was intermittently unavailable, pushing many people to compounded or alternative GLP-1s. Supply has since normalized but the shift to alternatives persists.

Full Comparison: Every Ozempic Alternative at a Glance

Alternative	Class	FDA status	Typical weight loss	Monthly cost (US)	Best for
Wegovy	GLP-1 (semaglutide)	FDA-approved (weight)	~15% at 68 weeks	$1,000-1,300	Semaglutide for weight loss
Mounjaro	GLP-1/GIP (tirzepatide)	FDA-approved (diabetes)	~21% at 72 weeks	$1,000-1,200	Diabetes + weight
Zepbound	GLP-1/GIP (tirzepatide)	FDA-approved (weight)	~21% at 72 weeks	$500-1,100	Strongest FDA-approved weight option
Saxenda	GLP-1 (liraglutide)	FDA-approved (weight)	~5-8% at 56 weeks	$1,300-1,500	Older liraglutide; daily injection
Victoza	GLP-1 (liraglutide)	FDA-approved (diabetes)	~5% secondary	$500-1,000	Diabetes; daily injection
Trulicity	GLP-1 (dulaglutide)	FDA-approved (diabetes)	~3-5% secondary	$900-1,000	Diabetes; gentler GI profile
Rybelsus	GLP-1 (oral semaglutide)	FDA-approved (diabetes)	~2-4% secondary	$900-1,000	Pill form, no injection
Compounded semaglutide	GLP-1 (semaglutide)	Clinical exceptions only (post-2025)	~15% at comparable dose	$200-400	Cheaper branded-equivalent
Compounded tirzepatide	GLP-1/GIP	Clinical exceptions only (post-2024)	~21% at comparable dose	$250-500	Cheaper tirzepatide access
Retatrutide (R-30)	Triple GLP-1/GIP/GCG	Research / Phase 3	~24% at 48 weeks	$150-300	Strongest weight-loss data
Survodutide	GLP-1/GCG dual agonist	Research / Phase 3	~19% at 46 weeks	$200-350	Similar mechanism to retatrutide
Cagrilintide	Amylin analog	Research / Phase 3	~10-15% stacked with sema	$100-200	Stacks with GLP-1 for synergy
AOD-9604	Growth hormone fragment	Research peptide	Modest, fat-targeted	$60-120	Fat loss without nausea
MOTS-c	Mitochondrial peptide	Research peptide	Metabolic, not direct	$80-150	Insulin sensitivity
CJC-1295 + Ipamorelin	GH secretagogues	Research peptides	Body recomp, not weight	$100-200	Muscle preservation
Qsymia	Phentermine + topiramate	FDA-approved (weight)	~10% at 56 weeks	$200-300	Oral, non-GLP-1
Contrave	Naltrexone + bupropion	FDA-approved (weight)	~5-9% at 56 weeks	$100-300	Cravings-focused
Metformin	Biguanide	FDA-approved (diabetes)	~2-5%	$5-20	Cheapest prescription option
Jardiance / Farxiga	SGLT-2 inhibitors	FDA-approved (diabetes)	~2-4%	$500-700	Diabetes + cardiovascular
Berberine	OTC supplement	Not FDA-regulated	~2-3% (modest)	$20-40	OTC baseline support
Psyllium husk	OTC fiber	Not FDA-regulated (food)	~1-3% satiety-driven	$10-20	Appetite control

FDA-Approved Ozempic Alternatives for Weight Loss

Zepbound (Tirzepatide) - The Strongest FDA-Approved Option

Zepbound (Eli Lilly) is tirzepatide approved specifically for chronic weight management. Its dual mechanism (GLP-1 + GIP receptor agonism) produced an average of 21% weight loss at 72 weeks in the SURMOUNT-1 trial. That is roughly 6-8 percentage points higher than semaglutide at comparable doses in head-to-head data.

Zepbound is the best pick for people who can tolerate GI side effects and want maximum FDA-approved weight loss. It is injected once weekly, titrated from 2.5mg up to 15mg over 4-6 months. See our tirzepatide for weight loss guide for dosing detail.

Wegovy (Semaglutide 2.4mg) - Same Molecule, Higher Dose

Wegovy is semaglutide (same active ingredient as Ozempic) at a higher max dose (2.4mg vs 2.0mg) and approved specifically for chronic weight management. Trial data shows ~15% weight loss at 68 weeks (STEP 1).

If Ozempic worked for you but you want the weight-loss indication covered by insurance, Wegovy is the direct move. Side-effect profile is essentially identical, with slightly more GI distress at the higher dose.

Saxenda (Liraglutide 3mg) - The Daily Injection Option

Older GLP-1, approved for weight management since 2014. Produces ~5-8% weight loss in trials, less than semaglutide or tirzepatide. Requires daily injection rather than weekly. Useful mostly in cases where newer drugs are not tolerated or not available. More GI side effects at daily dosing than weekly GLP-1s.

FDA-Approved Ozempic Alternatives for Type 2 Diabetes

Mounjaro (Tirzepatide)

Tirzepatide approved for type 2 diabetes. Same molecule as Zepbound, different FDA label. Excellent A1c reduction (roughly 1.8-2.4% at max dose) and the strongest weight-loss effect of any diabetes medication to date. First-line alternative for diabetics who want better weight loss than Ozempic delivers.

Trulicity (Dulaglutide)

Weekly GLP-1 from Eli Lilly. Gentler GI side-effect profile than Ozempic and Mounjaro, with somewhat less potent weight-loss effect (~3-5%). A reasonable option for people who had intolerable GI side effects on Ozempic and want to stay in the GLP-1 class.

Victoza (Liraglutide)

Daily liraglutide, diabetes indication. Same molecule as Saxenda but lower dose. Older and less convenient than weekly options, but still works well for glycemic control.

Rybelsus (Oral Semaglutide)

The pill form of semaglutide. Same active ingredient as Ozempic and Wegovy but taken orally. Bioavailability is low (1-2%), so the effective dose is much higher. Approved for type 2 diabetes. Good option for needle-averse patients willing to follow strict dosing rules (empty stomach, wait 30 minutes before eating).

Emerging Research Peptides: Retatrutide, Survodutide, Cagrilintide

Retatrutide - The Strongest Data Anywhere

Retatrutide is a triple agonist, activating GLP-1, GIP, and glucagon receptors simultaneously. In the Phase 2 trial (TRIUMPH), participants lost an average of 24.2% of body weight at 48 weeks at the top 12mg dose, with weight still declining at the endpoint (meaning more loss was likely if the trial had continued).

This is the strongest weight-loss data of any GLP-1-class drug ever tested. Phase 3 is ongoing; FDA approval is expected in 2026-2027.

Retatrutide is currently available only as a research peptide. Our retatrutide sourcing guide covers verified vendors.

Survodutide - GLP-1/Glucagon Dual Agonist

Boehringer Ingelheim's dual GLP-1/glucagon agonist. Phase 2 data showed ~19% weight loss at 46 weeks. Similar mechanism to retatrutide but dual rather than triple agonism. Phase 3 trials active.

Cagrilintide - The Stack Partner

Amylin analog that works through a different appetite-suppression pathway than GLP-1. On its own, modest weight loss. Stacked with semaglutide (as CagriSema), produces ~15-22% weight loss in trials, with potentially better muscle preservation than GLP-1 alone.

Compounded Semaglutide and Tirzepatide: What's Left After 2024-2025

This part changed significantly.

During the 2022-2024 shortage, compounding pharmacies were legally authorized to make semaglutide and tirzepatide. Millions of patients accessed these drugs at 1/3 to 1/5 the branded price. The FDA declared the shortage resolved for tirzepatide in October 2024 and for semaglutide in February 2025, triggering enforcement action that required most compounding pharmacies to stop producing the branded-equivalent versions.

Where things stand in 2026:

Compounded branded-equivalent versions: No longer broadly available. Most compounding pharmacies have discontinued or strictly limited production.
Personalized compounds with variations: Some clinics offer compounded versions with added ingredients (B12, amino acid cocktails, glycine) which may qualify under personalized-compounding exceptions. Legality is gray; prices similar to branded.
Research-grade semaglutide and tirzepatide: Still available through peptide vendors for research use; used in practice by individuals managing their own protocols. Not prescribed, not regulated as drugs.
Overseas telehealth: Some patients use international pharmacy services to access lower-cost versions with prescription; legal and quality risks vary.

For people who were using compounded GLP-1 before 2025, the practical options now are: switch to branded Wegovy/Zepbound (often at a manufacturer discount), move to compounded personalized versions where available, or use research-grade peptides.

[Image #1]

Non-GLP-1 Peptide Alternatives

For people who cannot tolerate GLP-1 GI effects, or who want to preserve muscle and target fat specifically.

AOD-9604 - Fat-Targeted Without Nausea

A fragment of human growth hormone that stimulates lipolysis (fat breakdown) without the broader metabolic effects of full GH. Does not cause nausea. Best stacked with diet and resistance training rather than relied on for appetite suppression. See our AOD-9604 dosage guide.

MOTS-c - Mitochondrial Peptide for Insulin Sensitivity

A mitochondrially-derived peptide that improves insulin sensitivity and metabolic efficiency at the cellular level. Not a direct weight-loss drug, but supports metabolic health in ways that make fat loss easier. Strong pairing for people transitioning off GLP-1s. See our MOTS-c guide.

CJC-1295 + Ipamorelin - Body Recomposition

A GHRH/GHRP stack that raises endogenous growth hormone, supporting muscle preservation during weight loss and modest fat loss without appetite effects. Good "exit stack" for people coming off GLP-1s who want to lock in muscle and continue recomposition. See our Ipamorelin + CJC-1295 protocol.

Top Pick R-30 Retatrutide (30mg) Research-grade retatrutide from Ascension Peptides. The strongest weight-loss data of any GLP-1-class compound tested (24.2% at 48 weeks). Exclusive 50% off — use code PEPTIDEDECK

Buy Retatrutide R-30

Non-GLP-1 Prescription Alternatives

Qsymia (Phentermine + Topiramate)

A combination of a stimulant-class appetite suppressant (phentermine) and an anti-seizure drug with known weight-loss effect (topiramate). FDA-approved for chronic weight management. Produces ~10% weight loss in trials. Side effects include dry mouth, insomnia, tingling, mood effects. Not for people with heart disease, hyperthyroidism, or glaucoma.

Contrave (Naltrexone + Bupropion)

Targets the reward and craving pathways rather than appetite directly. Produces ~5-9% weight loss at 56 weeks. Works best for emotional eaters and those with strong food cravings. Contraindicated with opioid use, uncontrolled hypertension, or seizure disorders.

Metformin - The Cheap Baseline

Standard diabetes medication, generic for decades. Produces modest weight loss (2-5%) through mechanisms that are still being clarified. Not a direct GLP-1 replacement but a reasonable starting point for prediabetic or insulin-resistant patients who cannot afford GLP-1s. Generic cost runs $5-20 per month.

SGLT-2 Inhibitors (Jardiance, Farxiga)

Cause glucose to be excreted in urine, producing modest weight loss (2-4%) and strong cardiovascular benefits in diabetics. Used in patients with diabetes plus heart failure or kidney disease. Not a primary weight-loss option but can stack with GLP-1s.

Over-the-Counter Ozempic Alternatives

Honest assessment: OTC options deliver a fraction of the effect of prescription GLP-1s. They are better framed as support tools than substitutes.

Berberine

Marketed as "nature's Ozempic" on TikTok. Produces ~2-3% weight loss in trials, better on glucose metabolism than actual weight loss. Standard dose: 500mg 2-3 times daily with meals. Mild GI side effects similar to metformin. Stacks well with GLP-1s or as a baseline for people not ready for injections.

Psyllium Husk

Soluble fiber that expands in the stomach, producing satiety and supporting blood sugar control. 5-15g daily, taken before meals with plenty of water. Produces modest weight loss (1-3%) through mechanical appetite suppression. Cheap, safe, and a legitimate complement to any other protocol.

Apple Cider Vinegar, Chromium, Green Tea Extract

Popular but weak. Effects are real but small, usually under 1-2% weight loss in trials. Reasonable as diet support, not as an Ozempic replacement.

Cheapest Ozempic Alternatives by Monthly Cost

Option	Monthly cost (US)	Effectiveness	Notes
Metformin (generic)	$5-20	Low (2-5% weight loss)	Cheapest Rx; diabetes focus
Psyllium husk	$10-20	Low (1-3%)	Over-the-counter support
Berberine	$20-40	Low (2-3%)	Over-the-counter; glucose focus
AOD-9604 (research peptide)	$60-120	Low-moderate (fat-targeted)	No nausea; research-grade
Retatrutide (research peptide)	$150-300	Highest (~24% at 48 wks)	Research-grade; strongest data
Contrave	$100-300	Moderate (5-9%)	Pill; cravings focus
Qsymia	$200-300	Moderate (~10%)	Pill; stimulant class
Compounded semaglutide (where available)	$200-400	High (~15%)	Limited post-2025

Which Ozempic Alternative Is Right for You?

Quick decision framework

Insurance covers GLP-1s: Move to Zepbound (best results) or Wegovy (same molecule as Ozempic)
Have diabetes, need better weight loss: Mounjaro is the clearest upgrade from Ozempic
Cost is the main issue: Metformin + berberine as baseline, or research-grade semaglutide/retatrutide
Cannot tolerate GLP-1 nausea: AOD-9604, Trulicity (gentler GLP-1), or Contrave
Want needle-free: Rybelsus (oral semaglutide), Qsymia, Contrave, or berberine
Worried about muscle loss: Pair any GLP-1 with CJC-1295 + Ipamorelin, high protein, and resistance training
Maximum weight loss, prescription not required: Research-grade retatrutide delivers the strongest clinical data
Natural only: Psyllium + berberine + structured diet and exercise

How to Switch from Ozempic to an Alternative

Ozempic to Zepbound or Wegovy

Same day transition is common. Some clinicians wait one full Ozempic dose cycle (7 days) before starting the new drug. Start at the lowest dose of the new drug regardless of Ozempic dose level; tirzepatide starts at 2.5mg, Wegovy at 0.25mg. Side effects reset with the new drug.

Ozempic to Compounded Semaglutide

If you can find a legal compounded source, dose should be matched 1:1 with your Ozempic dose. No washout needed because the molecule is identical. The main risk with compounded is purity and dosing accuracy; verify COAs.

Ozempic to Retatrutide

Wait one week after the last Ozempic dose before starting retatrutide to avoid double GLP-1 activation side effects. Start retatrutide at 0.5-1mg weekly and titrate up over 8-12 weeks. See our retatrutide dosing guide for full protocol.

Ozempic to Non-GLP-1

GLP-1 taper is not medically required but can reduce rebound hunger. A 4-week step-down (half dose for 2 weeks, quarter dose for 2 weeks, then stop) is a common approach. Start the replacement protocol during or just after the taper.

Who Should Not Use GLP-1 Alternatives

Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2: Avoid all GLP-1s
Severe gastroparesis: Avoid all GLP-1s
Active pancreatitis or recent history: Avoid GLP-1s
Pregnancy or trying to conceive within 2 months: Avoid all GLP-1s
Type 1 diabetes: GLP-1s are not a substitute for insulin
Children under 12: Most alternatives are not approved; Wegovy is approved for adolescents 12+
Severe kidney disease: Requires specialist guidance
Active eating disorder: All appetite-suppressing drugs risk worsening the condition

The Cost Picture: What You'll Actually Pay

US cost without insurance for 1 month, retail:

Ozempic: $900-1,200
Zepbound: $500-1,100 (manufacturer savings card can reduce significantly)
Wegovy: $1,000-1,300 (similar savings card)
Mounjaro: $1,000-1,200
Saxenda: $1,300-1,500
Victoza: $500-1,000
Trulicity: $900-1,000
Rybelsus: $900-1,000
Qsymia: $200-300
Contrave: $100-300
Metformin (generic): $5-20
Compounded semaglutide (where available): $200-400
Research-grade retatrutide: $150-300
Research-grade semaglutide: $100-200
Berberine (OTC): $20-40

Insurance coverage patterns: Most plans cover Ozempic, Mounjaro, Trulicity, Victoza, and Rybelsus for diabetes. Coverage for weight-loss indications (Wegovy, Zepbound, Saxenda, Qsymia, Contrave) is much more variable and often requires prior authorization and documented BMI thresholds.

Frequently Asked Questions

What is the best alternative to Ozempic?

For maximum FDA-approved weight loss: Zepbound (tirzepatide). For same-molecule with higher dose: Wegovy. For diabetes with better weight loss than Ozempic: Mounjaro. For the strongest weight-loss data overall (not yet approved): retatrutide, currently available only as a research peptide. For non-GLP-1 routes: Qsymia, Contrave, or metformin.

What can I take instead of Ozempic?

Prescription alternatives include Wegovy, Zepbound, Mounjaro, Trulicity, Victoza, Rybelsus, Saxenda, Qsymia, Contrave, and metformin. Emerging options include retatrutide, survodutide, and cagrilintide (research-grade). Non-GLP-1 peptides include AOD-9604, MOTS-c, and CJC-1295 + Ipamorelin. Over-the-counter: berberine, psyllium husk.

Is there a cheaper alternative to Ozempic?

Yes. Generic metformin runs $5-20 per month. Contrave runs $100-300. Compounded semaglutide (where legally available in 2026) runs $200-400. Research-grade semaglutide or retatrutide from verified peptide vendors runs $100-300. Over-the-counter berberine and psyllium cost $20-40 but deliver much smaller effects.

Is Zepbound better than Ozempic?

For weight loss, yes. Zepbound (tirzepatide) produced 21% weight loss at 72 weeks in SURMOUNT-1, roughly 6-8 percentage points higher than semaglutide at comparable doses. Tirzepatide's dual GLP-1/GIP mechanism appears to produce both more weight loss and somewhat better blood sugar control than semaglutide alone.

Is retatrutide better than Ozempic?

Clinically, yes, by a wide margin. Retatrutide's Phase 2 trial (TRIUMPH) showed 24.2% weight loss at 48 weeks at the 12mg dose, with participants still losing weight at the endpoint. No FDA-approved GLP-1 has matched this. The caveat: retatrutide is not yet FDA-approved (Phase 3 is ongoing), so current access is through research peptide vendors. FDA approval is expected in 2026-2027.

What is the most natural alternative to Ozempic?

Psyllium husk (fiber-driven satiety) and berberine (glucose regulation) are the two most-studied natural options. Neither matches Ozempic's effect size, but both are cheap, safe, and can be stacked with other approaches. A structured high-protein, whole-food diet combined with resistance training remains the non-medication baseline for sustainable weight management.

Is compounded semaglutide still available in 2026?

In a limited way. The FDA declared the semaglutide shortage resolved in February 2025, which triggered enforcement action against compounding pharmacies making standard branded-equivalent versions. Some personalized-compounding exceptions remain, and research-grade semaglutide continues to be available from peptide vendors for research use. Access is more restricted than it was in 2023-2024.

Can I switch from Ozempic to Mounjaro?

Yes. Many clinicians switch patients directly. Standard approach: finish the current Ozempic week, then start Mounjaro at the lowest dose (2.5mg) regardless of Ozempic dose level. Side effects reset with the new drug. Expect the first 4 weeks to feel similar to starting Ozempic originally.

What is the pill version of Ozempic?

Rybelsus. It contains the same active ingredient as Ozempic (semaglutide) in an oral tablet form. FDA-approved for type 2 diabetes. Bioavailability is low (1-2%), so it requires strict dosing rules: take on an empty stomach with no more than 4 ounces of water, then wait at least 30 minutes before eating or drinking anything else.

What alternative works best if Ozempic causes too much nausea?

Trulicity (dulaglutide) has the gentlest GI profile among weekly GLP-1s. Rybelsus (oral semaglutide) is sometimes better tolerated because the dose is smaller. AOD-9604 and other non-GLP-1 peptides cause no nausea. Contrave works through a non-GLP-1 mechanism and does not cause the severe GI effects of GLP-1 drugs.

Are peptides a legitimate Ozempic alternative?

For people managing their own protocols, yes. Research-grade semaglutide, tirzepatide, and retatrutide are molecularly identical to their branded counterparts. Quality and purity vary significantly by vendor, so COA verification matters. Non-GLP-1 peptides like AOD-9604 and MOTS-c are legitimate for different goals (fat targeting, insulin sensitivity) but are not direct Ozempic equivalents in terms of weight-loss mechanism or magnitude.

Can I get Ozempic alternatives without a prescription?

Over-the-counter: berberine, psyllium husk, and other supplements. Research-grade peptides (semaglutide, tirzepatide, retatrutide) are sold for research use without a prescription through peptide vendors; individual use is not the legal framing, and buyers should understand the regulatory gray zone. Truly prescription-free FDA-approved GLP-1 access does not exist in the US.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Prescription medications including Ozempic and its alternatives have serious potential side effects and interactions and should only be used under physician supervision. Compounded and research-grade options come with their own regulatory and quality considerations. Consult a licensed healthcare provider before starting, stopping, or switching any weight-loss or diabetes medication.